ESPCG to contribute to the EASL SLD Summit January 2025

Various  ESPCG members have contributed to the differentiation of SLD ( Steatotic Liver Disease) Trajectory. Following a series of meetings on different areas of management of SLD promoted by EASL the final objective has been to release a position paper for best management of SLD. The final document to be presented at the EASL Summit in Estoril ( Lisbon) 22-24 January 2025 with active participation of ESPCG  at the programme.